Researcher Profile Statistics: Valdeira, Ana S. C.
Geo Map
Region
#
NA - North America
29
AS - Asia, other
8
EU - Europe
7
OC - Oceania
4
AF - Africa
1
Unknown
2
Total
51
Country
#
US - United States of America
29
IE - Ireland
5
AU - Australia
4
SG - Singapore
4
CN - China
2
DE - Germany
1
ID - Indonesia
1
IN - India
1
MA - Morocco
1
PT - Portugal
1
other - Other Country
2
Total
51
City
#
New York
6
Dublin
5
Singapore
3
Brisbane
2
Melbourne
2
Ashburn
1
Coimbra
1
Jakarta
1
Navi Mumbai
1
North Bergen
1
other
28
Total
51
Most viewed items
#
ID: 60622 - Synthesis and Biological Evaluation of New Madecassic Acid Derivatives Targeting ERK Cascade Signaling
51
Total
51
Most type viewed
#
ID: all -
51
ID: other -
0
ID: journal -
0
ID: conference -
0
ID: book -
0
ID: thesis -
0
ID: selected -
0
Total
51
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2023
0 0
0 0 0 0
4 0 0 1
1 8
14
2024
2 1
8 12 4 5
5 0 0 0
0 0
37
Ever
51
Geo Map
Region | # |
---|---|
NA - North America | 29 |
AS - Asia, other | 8 |
EU - Europe | 7 |
OC - Oceania | 4 |
AF - Africa | 1 |
Unknown | 2 |
Total | 51 |
Country | # |
---|---|
US - United States of America | 29 |
IE - Ireland | 5 |
AU - Australia | 4 |
SG - Singapore | 4 |
CN - China | 2 |
DE - Germany | 1 |
ID - Indonesia | 1 |
IN - India | 1 |
MA - Morocco | 1 |
PT - Portugal | 1 |
other - Other Country | 2 |
Total | 51 |
City | # |
---|---|
New York | 6 |
Dublin | 5 |
Singapore | 3 |
Brisbane | 2 |
Melbourne | 2 |
Ashburn | 1 |
Coimbra | 1 |
Jakarta | 1 |
Navi Mumbai | 1 |
North Bergen | 1 |
other | 28 |
Total | 51 |
Most viewed items | # |
---|---|
ID: 60622 - Synthesis and Biological Evaluation of New Madecassic Acid Derivatives Targeting ERK Cascade Signaling | 51 |
Total | 51 |
Most type viewed | # |
---|---|
ID: all - | 51 |
ID: other - | 0 |
ID: journal - | 0 |
ID: conference - | 0 |
ID: book - | 0 |
ID: thesis - | 0 |
ID: selected - | 0 |
Total | 51 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 1 | 1 | 8 | 14 |
2024 | 2 | 1 | 8 | 12 | 4 | 5 | 5 | 0 | 0 | 0 | 0 | 0 | 37 |
Ever | 51 |